Evaluating Efficacy of GuessWhat Mobile App Therapy for Children With Autism
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04739982 |
Recruitment Status :
Recruiting
First Posted : February 5, 2021
Last Update Posted : December 14, 2022
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Autism Autism Spectrum Disorder | Device: GuessWhat Mobile App | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 600 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Evaluating Mobile Game Based Therapy Among Children With Autism, A Randomized Clinical Trial. |
Actual Study Start Date : | July 7, 2021 |
Estimated Primary Completion Date : | December 31, 2023 |
Estimated Study Completion Date : | January 31, 2024 |

Arm | Intervention/treatment |
---|---|
Experimental: Treatment
The GuessWhat app is a charades style game and app that engages parent and child in fluid social interaction where the parent must guess what the child is acting out based on the prompt shown on the phone screen. Participants will use their own personal phone to download the study app. Parent and child will be encouraged to play using the emojis and emotion game mode at least 3 individual game sessions per week. Parents are asked to play GuessWhat with their child 3-4 times per week for 4 weeks.
|
Device: GuessWhat Mobile App
The GuessWhat app is a charades style game and app that engages parent and child in fluid social interaction where the parent must guess what the child is acting out based on the prompt shown on the phone screen. Participants will use their own personal phone to download the study app. Parent and child will be encouraged to play using the emojis and emotion game mode at least 3 individual game sessions per week. Parents are asked to play GuessWhat with their child 3-4 times per week for 4 weeks. |
No Intervention: Treatment as Usual
Participants in control group will continue their treatment as usual.
|
- Change in parent reported socialization based on the Vineland Adaptive Behavior Scales 3rd Edition (VABS-3) Parent/Caregiver Socialization Subscale, from baseline to week 4 [ Time Frame: Baseline (Week 0), Week 4 ]Vineland Adaptive Behavior Scales, 3rd edition (VABS-3) Socialization subscale of the Parent/Caregiver Comprehensive form will be administered online to the parents. Scores from the socialization domain of the VABS-III reflects one's functioning in social situations. The socialization subscale is up to 112 items depending on age and development, where raw scores are converted to IQ-type standard scores--v-scale scores (M=15, SD=3) where scores range from 1 to 24, and factor in age equivalents, growth scale values, and higher scores indicate better adaptive functioning.
- GuessWhat App Usage Data [ Time Frame: Week 4 ]App usage data comprised of game decks selected, number of game sessions started, ended, and shared.
- Parent reported feedback [ Time Frame: Week 4 ]Qualitative survey delivered to parent participants at Week 4 to understand preferred games, overall feedback including likes and dislikes, any technical issues they experienced or challenges in using the app.
- Change in Parental Stress Scale - from baseline to week 4 [ Time Frame: Baseline (Week 0), Week 4 ]The Parental Stress Scale is an 18-item parent report scale that evaluates the extent of parent stress. Scores range from 18-90, where higher scores indicate a higher level of Parental stress.
- Change in Emotion Recognition from baseline to week 4 [ Time Frame: Baseline (Week 0), Week 4 ]Study team will use an image based emotion recognition task where participants will select the emotion that corresponds to an emotional facial image in the form of a GIF (Graphics Interchange Format) image. Participants will select 1 of 8 available Ekman emotion labels for 16 facial emotional image stimuli presented in random order. Correct responses will be measured against a predetermined majority rules consensus of the emotional content of the GIFs.
- mobile autism risk assessment score at baseline [ Time Frame: Baseline (Week 0) ]Study team will use a level 2 screening tool that has been validated in several studies and that uses a brief parent/caregiver questionnaire with a 2 minute home video to generate a classification score that indicates severity of the autism phenotype (ranging from no autistic symptoms to severe autism) as well as confidence in the classification.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 3 Years to 12 Years (Child) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Parent who is at least 18 years old of child with autism.
- Child with autism is between 3 and 12 years old at time of baseline data collection.
Exclusion Criteria:
- Parent is unable to read English.
- Parent does not have an Android or iOS smartphone compatible with GuessWhat App--the app will be available on Android after further development and we will notify interested families when it becomes available.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04739982
Contact: Yordan Penev, MSc | (650) 497 - 9214 | ypenev@stanford.edu | |
Contact: Kaiti Dunlap, MRes | 650-497-9214 | kaiti.dunlap@stanford.edu |
United States, California | |
Stanford University | Recruiting |
Stanford, California, United States, 94305 | |
Contact: Kaiti Dunlap, MRes 650-497-9214 kaiti.dunlap@stanford.edu | |
Principal Investigator: Dennis P Wall, PhD |
Principal Investigator: | Dennis P Wall, PhD | Stanford University |
Documents provided by Dennis Paul Wall, Stanford University:
Responsible Party: | Dennis Paul Wall, Associate Professor, Stanford University |
ClinicalTrials.gov Identifier: | NCT04739982 |
Other Study ID Numbers: |
60181 |
First Posted: | February 5, 2021 Key Record Dates |
Last Update Posted: | December 14, 2022 |
Last Verified: | December 2022 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Yes |
Supporting Materials: |
Study Protocol Statistical Analysis Plan (SAP) Informed Consent Form (ICF) |
Time Frame: | within 1 year after study completion |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
digital health mhealth autism intervention behavioral therapy |
Autistic Disorder Autism Spectrum Disorder Child Development Disorders, Pervasive Neurodevelopmental Disorders Mental Disorders |